IDH1 and neoplasm: Conversely, in Figure 3, patients included within the IDH mutant subgroup may include patients with both lower-risk IDH mutant, 1p and 19q co-deleted tumours, as well as patients with intermediate IDH mutant, 1p and 19 intact, ATRX-deleted tumors.